Biopôle-based DigeHealth SA, a Swiss medtech company developing a wearable device that “listens to the gut” to support early detection and management of gastro-intestinal complications, today announced the successful closing of a CHF 1.25 million Seed round.
The round was led by Medin Fund Management with the participation of Lichtsteiner Foundation and will enable DigeHealth to accelerate the product development, clinical validation, and regulatory approval processes. Digital Africa and Joylab SA also participated in the round, adding valuable support to DigeHealth’s continued development.
